Skip to content
lifestyle.fictiontalk.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Senti Biosciences, Inc.
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
February 13, 2026
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026
February 3, 2026
←
Previous Page
1
2